Tango Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Highlights

Go back to Tango Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Highlights
(NASDAQ: TNGX) Delayed: 21.75 -1.74 (7.41%)
Previous Close $23.49    52 Week High
Open $23.33    52 Week Low
Day High $23.55    P/E N/A 
Day Low $21.72    EPS
Volume 6,242,929